Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-01-17, Stock:ABBV, The news for the past five days is as follows:
2019-01-10: NEWS1: 6 High-Cap Stocks Paying High Dividend Yields.NEWS2: 3 Big Reasons Why AbbVie Isn't Worried About Humira.NEWS3: 3 Big Reasons Why AbbVie Isn't Worried About Humira.NEWS4: 3 Dividend Stocks That Pay You Better Than Coca-Cola Does.NEWS5: 3 Dividend Stocks That Pay You Better Than Coca-Cola Does.NEWS6: Ex-Dividend Reminder: Publix Super Markets, AbbVie and Quest Diagnostics.NEWS7: Ex-Dividend Reminder: Publix Super Markets, AbbVie and Quest Diagnostics.NEWS8: Top Ranked Momentum Stocks to Buy for January 10th.NEWS9: Top Ranked Momentum Stocks to Buy for January 10th.NEWS10: 3 Dividend Stocks That Pay You Better Than Coca-Cola Does.NEWS11: 3 Big Reasons Why AbbVie Isn&apos;t Worried About Humira.NEWS12: Top Ranked Momentum Stocks to Buy for January 10th.
2019-01-11: NEWS1: 5 Reasons Why Investors Should Buy Novo Nordisk (NVO) in 2019.NEWS2: Noteworthy Friday Option Activity: TSLA, THS, ABBV.NEWS3: Noteworthy Friday Option Activity: TSLA, THS, ABBV.NEWS4: 3 Back-of-the-Shelf Consumer Stocks With Growth and Income.NEWS5: Top Ranked Momentum Stocks to Buy for January 11th.NEWS6: Top Ranked Momentum Stocks to Buy for January 11th.NEWS7: Top Ranked Momentum Stocks to Buy for January 11th.NEWS8: Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet.NEWS9: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for January 14, 2019.NEWS10: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for January 14, 2019.NEWS11: The Implied Analyst 12-Month Target For FTC.NEWS12: The Implied Analyst 12-Month Target For FTC.NEWS13: [$$] Senator Collins Presses HHS to Reform Drug Rebate System.
2019-01-14: NEWS1: Pharma Stocks Topple After House Dems Launch Drug-Pricing Probe.NEWS2: U.S. lawmaker launches investigation into pharma drug pricing.NEWS3: Merck or AbbVie: Which Has the More Robust Revenue Trajectory?.NEWS4: House Democrats launch drug-pricing probe into a dozen major health-care companies.NEWS5: Analysts’ Recommendations for AbbVie in January.NEWS6: Top Ranked Growth Stocks to Buy for January 14th.NEWS7: Top Ranked Growth Stocks to Buy for January 14th.NEWS8: Analysts’ Recommendations for Merck & Co. in January.NEWS9: Top Ranked Growth Stocks to Buy for January 14th.
2019-01-15: NEWS1: 3 of the Top Big Pharma Stocks to Buy Now.NEWS2: Drug companies greet 2019 with U.S. price hikes.NEWS3: Merck or AbbVie: Which Has the Better Cost Structure?.NEWS4: Merck or AbbVie: Which Has More Robust Margins?.NEWS5: Merck or AbbVie: Which Has a Stronger Earnings Trajectory?.
2019-01-16: NEWS1: Kitov Pharma's Stock Up on Anti-Cancer Candidate Findings.NEWS2: 3 Healthcare Stocks That Will Keep Your Portfolio Healthy.NEWS3: Will Dividend Stocks be the Hot Stocks of 2019?.NEWS4: Will Dividend Stocks be the Hot Stocks of 2019?.NEWS5: Will Dividend Stocks be the Hot Stocks of 2019?.NEWS6: Noteworthy ETF Outflows: IUSG, NEE, ABBV, ISRG.NEWS7: Noteworthy ETF Outflows: IUSG, NEE, ABBV, ISRG.NEWS8: Merck or AbbVie: Which Company Returns More Value to Shareholders?.NEWS9: Katz:  Markets are looking past several negative headline....NEWS10: 3 of the Top Big Pharma Stocks to Buy Now.NEWS11: 3 of the Top Big Pharma Stocks to Buy Now.

Answer: Rise